had widely patent SMAs at last follow-up. Mean total seal zone length was 41.4 mm. There was a single secondary intervention for asymptomatic SMA stenosis requiring stent placement 1 year after F-EVAR. There were no Type IA endoleaks and no endoleaks related to SMA fenestrations. Five patients of the entire cohort (4.7%) required SMA stenting at the index procedure. Three of these patients had prior EVAR (n ¼2) or open repair (n ¼ 1), One patient had a pre-existing critical SMA stenosis and underwent planned SMA stenting, and in one patient, the graft was deployed imprecisely and low, and the SMA was successfully stented from a brachial approach.
IF09.
Image Objective: Although endovascular aneurysm repair (EVAR) has minimal perioperative morbidity and mortality, it is still associated with increased radiation exposure and contrast material use. Three-dimensional (3D) fusion computed tomography (CT) technology has the potential to revolutionize endovascular management of aneurysms by mitigating radiation exposure. Currently available 3D fusion devices use hardware-based (ie, operating table) tracking to position the overlay on the fluoroscopic image. This can be labor-intensive and lead to inaccurate overlay. Recently, our institution implemented a novel cloud-based 3D fusion system, which has been shown in prior studies to be highly accurate. This system uses the patient's vertebral anatomy rather than the operating table to register and produce the overlay, and it can be used with any imaging system, including C arm. The purpose of this study was to investigate the impact of this new 3D fusion system on EVAR.
Methods: Our institutional database was reviewed to identify patients who underwent elective EVAR or fenestrated EVAR. Patients treated using 3D fusion CT were compared with patients treated in the immediate 6 months before the implementation of 3D fusion CT at our institution. Primary end points included the patient's radiation exposure, contrast material use, fluoroscopy time, and procedure time.
Results: A total of 108 patients (67 before vs 41 after 3D fusion CT implementation) underwent EVAR or fenestrated EVAR from October 2016 through December 2017. There was a significant decrease in radiation exposure (3006 vs 2112 mGy; P ¼ .015), fluoroscopy time (36.8 vs 27.9 minutes; P ¼ .022), and procedure time (163.7 vs 127.5 minutes; P ¼ .007) with cloud-based digitally registered intraoperative 3D fusion CT. There was no difference in contrast material use (78 vs 73.9 mL; P ¼ .183) between the two groups (Table) .
Conclusions: The results of this study demonstrate that the use of intraoperative image-based 3D fusion CT during EVAR decreases radiation exposure, fluoroscopy time, and procedure time. This novel technology has the potential to improve clinical outcomes, to reduce costs, and to broaden the application of 3D fusion imaging.
Author Disclosures: M. Cox: Nothing to disclose; B. Gilmore: Nothing to disclose; C. Long: Nothing to disclose; R. McCann: Nothing to disclose; U. Nag: Nothing to disclose; C. Shortell: Nothing to disclose; K. W. Southerland: Nothing to disclose; M. Turner: Nothing to disclose IF10. Objective: In infrainguinal bypass for arteriosclerosis obliterans, the association between ambulatory status (AS) and graft performance is not well studied. The aim of this study was to elucidate the relationship between the postoperative AS and the time course of graft performance.
Methods: From January 2013 to June 2017, there were 179 bypass grafts distal to the popliteal artery with vein grafts enrolled; 35 grafts that were followed-up <6 months were excluded, and 144 grafts were finally enrolled. They were classified into two groups based on the postoperative AS: ambulation group (AG; n ¼ 91), including consistently ambulatory patients and patients who regained ambulation after rehabilitation; and non-AG (NAG; N ¼ 53), including bedridden status and patients with wheelchair or walker with limited physical activity. Graft flow (GF) and graft caliber (GC) were measured by duplex ultrasound, which was performed 1 month after surgery, every 3 months within 2 years, and every 6 months thereafter. GF ratio (GFr) and GC ratio (GCr) were calculated, dividing each measured value by the initial value within 1 month after surgery, and then the GFr and GCr change over time in relation to postoperative AS was analyzed, using a mixed model approach with a univariate split-plot analysis of variance and multivariate analysis of variance.
Results: Time after surgery and AS over time had significant influence on both GFr change (F ¼ 7.79 and 5.01, respectively; P < .0001) and GCr change (F ¼ 3.38 and 3.40, respectively; P < .0001). The trend of GFr and GCr change over time differed significantly between AG and NAG. In regard to GFr, AG maintained the same level of initial value throughout the time course (1 year: 0.93; P ¼ 1.0), whereas NAG showed marked decrease immediately after surgery and subsequent gradual decrease (3 months: 0.73 [P ¼ .0009]; 1 year: 0.58 [P < .0001]). GCr showed the same trend: AG maintained the initial value over time, whereas NAG showed gradual decrease (3 months: 0.94 [P ¼ .022]; 1 year: 0.91 [P ¼ .0005]). In regard to patency, there was no significant difference in primary patency (1 year: 63.8% in AG, 57.8% in NAG; P ¼ .30), but secondary patency was significantly better in AG (1 year: 96.6% in AG, 88.2% in NAG; P ¼ .012).
Conclusions: Postoperative ambulation maintained graft performance including flow and caliber, whereas non-AS showed gradual impairment of graft performance. Ambulatory function may have a protective effect on graft function and lead to subsequent good clinical outcomes.
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